Get the Stockscreener App
78.10
0.18%
0.0597
Hologic Inc stock is traded at $78.10, with a volume of 86,050.
It is up +0.18% in the last 24 hours and down -3.66% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$78.04
Open:
$78.18
24h Volume:
86,050
Relative Volume:
0.06
Market Cap:
$18.09B
Revenue:
$4.03B
Net Income/Loss:
$789.50M
P/E Ratio:
40.47
EPS:
1.93
Net Cash Flow:
$1.15B
1W Performance:
+0.83%
1M Performance:
-3.66%
6M Performance:
+4.87%
1Y Performance:
+8.72%
1-Day Range:
$77.48
$78.49
1-Week Range:
$77.46
$79.27
52-Week Range:
$67.59
$84.67
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| HOLX | 78.26 | 18.09B | 4.03B | 789.50M | 1.15B | 1.93 |
| ISRG | 545.80 | 191.57B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 221.99 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.38 | 42.29B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 241.49 | 35.10B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 311.56 | 22.14B | 2.88B | 499.60M | 321.60M | 7.41 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Do Wall Street Analysts Like Hologic Stock? - Barchart
Ontario Teachers Pension Plan Board Lowers Stock Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Invests $3.16 Million in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Portable Medical Devices Market Overall Study Report 2024-2031 - openPR
HOLX (Hologic) Financial Strength : 7 (As of Sep. 2024) - GuruFocus.com
Hologic Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
Nuance Investments LLC Cuts Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Implied Volatility Surging for Hologic (HOLX) Stock Options - MSN
Breast Cancer Diagnostic Market to Witness Massive Growth | Major Giants AstraZeneca, Becton, Hologic, Inc. - openPR
Hologic Inc. stock outperforms competitors despite losses on the day - MarketWatch
Parnassus Investments LLC Sells 105,080 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Natixis Advisors LLC Has $27.61 Million Stake in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Inc. stock rises Monday, still underperforms market - MarketWatch
Is Weakness In Hologic, Inc. (NASDAQ:HOLX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Simply Wall St
North America Diagnostic Imaging Market 2024-2031 Revenues - openPR
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by ING Groep NV - MarketBeat
Hologic Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Cornercap Investment Counsel Inc. Has $1.40 Million Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Should You Retain Hologic Stock in Your Portfolio Now? - Yahoo Finance
Hologic Inc.: Expanding Diagnostic Assay Portfolio For A Competitive Edge!Major Drivers - Smartkarma
T. Rowe Price Investment Management, Inc. Reduces Stake in Hologic Inc. - GuruFocus.com
Hologic Inc. stock underperforms Thursday when compared to competitors - MarketWatch
William Blair Has Optimistic Outlook of Hologic Q2 Earnings - MarketBeat
Hologic to Webcast Presentations at Upcoming Investor Conferences - Marketscreener.com
Hologic to Present at Three Major Healthcare Investment Conferences in Q4 | HOLX Stock News - StockTitan
12,585 Shares in Hologic, Inc. (NASDAQ:HOLX) Acquired by Entropy Technologies LP - MarketBeat
Entropy Technologies LP Buys Shares of 12,585 Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Holdings Raised by Principal Financial Group Inc. - MarketBeat
Hologic (NASDAQ:HOLX) Upgraded to Buy at StockNews.com - MarketBeat
William Blair Has Pessimistic Outlook of Hologic Q1 Earnings - MarketBeat
Hologic Inc. stock outperforms competitors on strong trading day - MarketWatch
Victory Capital Management Inc. Reduces Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Biopsy Devices Market: Size, Share, and Growth Trends with - openPR
Van ECK Associates Corp Invests $725,000 in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Digital Radiography Systems Market Forecasted for Major - openPR
Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family - Quantisnow
Versor Investments LP Invests $1.68 Million in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
HIV Diagnostics Test Market Detailed In New Research Report 2024 - openPR
Hologic Beats on EPS But GAAP Results Lag - AOL
Hologic Updates Executive Compensation Agreements for 2025 - TipRanks
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock? - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Olstein Capital Management L.P. - MarketBeat
Leerink Partnrs Has Positive Outlook for Hologic Q2 Earnings - MarketBeat
Leeward Investments LLC MA Decreases Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
National Pension Service Sells 15,791 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Robeco Institutional Asset Management B.V. Purchases 26,723 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
BioZorb Lawsuit - Lawsuit Information Center Blog
Hologic Inc. stock rises Wednesday, still underperforms market - MarketWatch
Leerink Partnrs Has Bearish Estimate for Hologic Q1 Earnings - MarketBeat
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):